Immunomedics Inc (IMMU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2015 | 06-2014 | 06-2013 | 06-2012 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,124 | -35,531 | -11,486 | 1,265 | -14,412 |
| Depreciation Amortization | 1,498 | -1,777 | 959 | 1,368 | 1,239 |
| Accounts receivable | 272 | -63 | 67 | 54 | -288 |
| Other Working Capital | 4,731 | 3,349 | 2,502 | 193 | -226 |
| Other Operating Activity | 2,627 | 3,331 | 2,059 | 2,029 | 1,502 |
| Operating Cash Flow | $-38,996 | $-30,690 | $-5,900 | $4,908 | $-12,186 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -51,816 | -44,116 | N/A | N/A | N/A |
| PPE Investments | -924 | -378 | -595 | -568 | -606 |
| Sale Of Investment | N/A | 9,024 | N/A | N/A | 9,545 |
| Other Investing Activity | 0 | 400 | 138 | 0 | 279 |
| Investing Cash Flow | $-52,740 | $-35,070 | $-458 | $-568 | $9,218 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 100,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 2,960 | 31,609 | 14,785 | 1,582 | 244 |
| Common Stock Repurchased | N/A | N/A | -39 | N/A | N/A |
| Other Financing Activity | -4,243 | -332 | 19 | 73 | -96 |
| Financing Cash Flow | $98,717 | $31,277 | $14,765 | $1,655 | $147 |
| Exchange Rate Effect | -489 | 119 | 80 | -255 | 385 |
| Beginning Cash Position | 6,962 | 41,326 | 32,838 | 27,098 | 29,533 |
| End Cash Position | 13,453 | 6,962 | 41,326 | 32,838 | 27,098 |
| Net Cash Flow | $6,491 | $-34,365 | $8,488 | $5,741 | $-2,436 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,996 | -30,690 | -5,900 | 4,908 | -12,186 |
| Capital Expenditure | -924 | -378 | -595 | -568 | -606 |
| Free Cash Flow | -39,921 | -31,068 | -6,495 | 4,340 | -12,792 |